Français
Contact us
Help
Search
Canada Site
A-Z Index
Consultations
Media Room
It's Your
Health
Home
About Health Canada
Consumer Product Safety
Diseases & Conditions
Drugs & Health Products
Adverse Reaction Information
Advisories, Warnings & Recalls
Biologics, Radio-
pharmaceuticals & Genetic Therapies
Compliance & Enforcement
Controlled Substances & Precursor Chemicals
Drug Products
International Activities
MedEffect
Medical Devices
Medical Use of Marihuana
Natural Health Products
Public Involvement & Consultations
Regulatory Requirements for Advertising
Special Access to Drugs & Health Products
Substances: Problematic Use
Veterinary Drugs
Legislation & Guidelines
Reports & Publications
Emergencies & Disasters
Environmental & Workplace Health
First Nations & Inuit Health
Food & Nutrition
Health Care System
Healthy Living
Science & Research
Government
Health Partners
Need
Larger
Text?
Home
>
Drugs & Health Products
>
MedEffect
>
Adverse Reaction Reporting
>
Guidance Documents
Draft Guidance Document for Industry - Reporting Adverse Reactions to Marketed Health Products
Date: 2006-10-30
Canadian Adverse Drug Reaction Monitoring Program (CADRMP) Guidelines for the Voluntary Reporting of Suspected Adverse Reactions to Health Products by Health Professionals and Consumers
Date: 2006-05-11
Draft Guidance Document: Submission of Pharmacogenomic Information
Date: 2006-03-07
Guidance Document for Industry:Issuance of Health Professional Communications and Public Communications by Market Authorization Holders
Guidelines for the Canadian Pharmaceutical Industry on Reporting Adverse Reactions to Marketed Drugs (Vaccines Excluded)
Date: 2001-07-01
Vaccines: Guidelines for Reporting Adverse Events Associated with Vaccine Products
Reporting of Adverse Drug Reactions - clarifications
Medical Devices Inspectorate
Medical Devices: Mandatory and Voluntary Problem Reporting for Medical Devices
Medical Devices: Product Recall Procedures
Last Updated: 2006-11-22
Important Notices